After 23 years of follow-up, the European Randomized Study of Screening for Prostate Cancer (ERSPC) confirmed a 13% lower ...

Please provide your email address to receive an email when new articles are posted on . A deep-learning algorithm detected prostate lesions on multiparametric MRI and tracked lesions throughout the ...

Nearly all men with prostate cancer treated with androgen receptor (AR) signaling inhibitors (ARSIs) develop resistance via diverse mechanisms including constitutive activation of the AR pathway, ...

DEAR DR. ROACH: My husband is 89 and taking amiodarone. He had a heart attack and is taking iron infusions for anemia. He was diagnosed with prostate cancer. His PSA level is over 300 ng/mL, but his ...

Toronto - (February 4, 2021) The results of a Phase III randomized clinical trial have shown that when it comes to detecting clinically significant prostate cancer, Magnetic Resonance Imaging (MRI) ...

We estimate the NHS could potentially save £millions annually by greater use of the generic version of abiraterone rather than using enzalutamide and apalutamide, the other treatments we recommend at ...

Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is conducting a Phase 1b clinical study ...

CLEVELAND, Ohio – Women with chest pain waited longer for ER evaluation, and a man’s risk of dying from prostate cancer increases the more belly fat he has, two separate studies suggest. Cleveland.com ...

Men with incurable prostate cancer are facing a “postcode lottery of care” a charity has warned after it raised concerns that ...

Retrospective evaluation of GM-CSF, low-dose cyclophosphamide, and celecoxib on PSA doubling time (DT) in men with prostate cancer and PSA relapse after surgery or radiation. Background: Treatment of ...